Advances in Biomarkers for Neurodegenerative Diseases

Dear Colleagues,

Due to the increasing aging population in most countries, the prevalence of neurodegenerative diseases is expected to rise dramatically, with important socio-economic impacts. Among the neurodegenerative diseases, Alzheimer’s disease (AD) and Parkinson’s disease (PD) are the two most common pathologies leading patients to a progressively reduced quality of life and autonomy and then to disability. Although significant progress has been made recently, the identification of new biomarkers for neurodegenerative diseases represents a great need in order to anticipate the diagnosis, improve diagnostic accuracy, monitor drug efficacy in clinical trials, and develop effective disease-modifying and tailored therapies.

Hence, this Special Issue aims to collect the most recent advances in the identification of biomarkers for neurodegenerative disease, with a particular focus on AD, PD and amyotrophic lateral sclerosis (ALS). Contributions on new susceptibility/trait markers, diagnostic/state markers and progression markers for AD, PD, ALS and other neurodegenerative diseases are welcome. Original research articles focusing on either “wet” or “dry” biomarkers for neurodegenerative diseases, deriving from genetic, epidemiologic, biochemical, -omics, epigenetic, histologic, imaging, and other tech-based assessments, will be greatly appreciated, as well as review articles summarizing and discussing the currently available biomarkers for neurodegenerative diseases.

Dr. Gessica Sala
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the Special Issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-anonymized peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomolecules is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.